Anticoagulant Treatment of Retinal Venous Occlusion

Vannas, Salme; Raitta, Christina

doi:10.1016/0002-9394(66)91912-x

Cited by 54 publications

(19 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Central retinal vein occlusion (CRVO) is an uncommon disease in young subjects, while it is frequently seen in adult and old persons [1][2][3]. CRVO of the youth has been the object of many studies; however some questions still remain open.…”

Section: Introductionmentioning

confidence: 99%

Central retinal vein occlusion in young people

1992

View full text Add to dashboard Cite

In a study performed on 20 subjects with central retinal vein occlusion (CRVO) aged 40 years or less we found the ischemic form in 20%. Disc edema was a common finding at the onset, while macular edema was less frequently seen. Systemic or ocular disorders that could be related with the development of the CRVO were often found; a patient was affected with myasthenia gravis and another with Sturge-Weber syndrome: these two diseases were not previously reported in association with CRVO. In only two of the 11 patients followed-up the visual acuity improved. The visual prognosis in CRVO of young people is often poor; the more frequent cause of the reduced visual acuity is chronic cystoid macular edema.

show abstract

Section: Introductionmentioning

confidence: 99%

Central retinal vein occlusion in young people

1992

View full text Add to dashboard Cite

show abstract

“…The majority of these treatments, including anti-coagulation, fibrinolysis, and low molecular weight dextran, have been generally unrewarding and have been largely discarded (Duff et all., 1951;Lindeke & Musler, 1961;Mikuni & Kumura, 1961;Vannas & Raitta, 1966;Antoine et al, 1967;Lohse & Weller, 1969).…”

Section: (Belfast)mentioning

confidence: 99%

Tributary vein obstruction pathogenesis and treatment of sequelae

Archer

1976

Doc Ophthalmol

View full text Add to dashboard Cite

“…Si nous comparons nos résultats avec les données de la littérature pour l'ensemble des thromboses, nous voyons que le pourcentage de vision finale supérieure à 0,1 a passé de 40%, avant l'ère des anticoagulants à 59% dans le série de Vannas et Raitta [3] avec anticoagulants (héparine ou dicoumariniques), pour atteindre 81% dans notre petite série avec anticoagulation héparinique, suivi, pour les thromboses de la veine cen trale, d'un traitement protecteur des plaquettes sanguines. …”

Section: Thromboses Veineusesunclassified